InvestorsHub Logo
Post# of 252869
Next 10
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

Re: DewDiligence post# 173460

Thursday, 01/30/2014 4:28:41 PM

Thursday, January 30, 2014 4:28:41 PM

Post# of 252869
Insulin FoB wasn't the reason. Reason was slower growth of Victoza, introduction of generic Prandin.

NVO's massive (more than 100 slides) presentation today:

http://www.novonordisk.com/images/investors/investor_presentations/2014/IR_presentations/Q4_2013_Investor_presentation_Cph.pdf
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.